Overcoming immunotherapy resistance in NSCLC
- Author(s)
- MacManus, M; Hegi-Johnson, F;
- Details
- Publication Year 2022-02,Volume 23,Issue #2,Page 191-193
- Journal Title
- Lancet Oncology
- Publication Type
- Commentary
- Keywords
- *Carcinoma, Non-Small-Cell Lung/drug therapy/genetics; Humans; Immunotherapy/adverse effects; *Lung Neoplasms/drug therapy/genetics
- Department(s)
- Radiation Oncology
- PubMed ID
- 35033225
- Publisher's Version
- https://doi.org/10.1016/S1470-2045(21)00711-7
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-01-31 03:38:46
Last Modified: 2025-01-31 03:40:50